title: Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment.
authors.affiliation: N.N. Petrov Institute of Oncology, St. Petersburg, Russia, St.Petersburg Pediatric Medical Academy, St.Petersburg, Russia N.N. Petrov Institute of Oncology, St. Petersburg, Russia City Oncological Hospital, St. Petersburg, Russia Institute of Pulmonology, St. Petersburg, Russia Regional Oncological Hospital, Ryazan, Russia Institute of Pulmonology, St. Petersburg, Russia N.N. Petrov Institute of Oncology, St. Petersburg, Russia St. Petersburg Pediatric Medical Academy, St.Petersburg, Russia N.N. Petrov Institute of Oncology, St. Petersburg, Russia N.N. Petrov Institute of Oncology, St. Petersburg, Russia, St.Petersburg Pediatric Medical Academy, St.Petersburg, Russia, I.I. Mechnikov North-Western Medical University, St. Petersburg, Russia.
authors.forename: Aglaya G
authors.initials: AG
authors.lastname: Iyevleva
authors.forename: Natalia V
authors.initials: NV
authors.lastname: Mitiushkina
authors.forename: Nina A
authors.initials: NA
authors.lastname: Karaseva
authors.forename: Sergey V
authors.initials: SV
authors.lastname: Orlov
authors.forename: Larisa N
authors.initials: LN
authors.lastname: Volodina
authors.forename: Yulia E
authors.initials: YE
authors.lastname: Kulikova
authors.forename: Alexandra M
authors.initials: AM
authors.lastname: Lozhkina
authors.forename: Alexandr O
authors.initials: AO
authors.lastname: Ivantsov
authors.forename: Vladislav I
authors.initials: VI
authors.lastname: Tiurin
authors.forename: Alexandr V
authors.initials: AV
authors.lastname: Togo
authors.forename: Evgeny N
authors.initials: EN
authors.lastname: Imyanitov
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D000595:Amino Acid Sequence; D001483:Base Sequence; D018287:Carcinoma, Large Cell / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D005091:Exons / Q000235:genetics*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008875:Middle Aged; D008969:Molecular Sequence Data; D016254:Mutagenesis, Insertional / Q000235:genetics*; D009367:Neoplasm Staging; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; C512478:EGFR protein, human; D066246:ErbB Receptors; D000077156:Gefitinib